The 2023 data on European sold production of medicaments containing alkaloids or derivatives highlights significant disparities in performance across countries. Ireland leads with a substantial value and an 8.52% year-on-year increase, indicating robust growth. Conversely, France and the UK observed slight declines, while Germany remained stable. Belgium and Greece exhibited strong growth exceeding 10%, and notably, Sweden’s production surged by over 95%, suggesting emerging potential in the sector.
Future trends to watch include continued growth in high-performing markets like Ireland and potential market recovery in countries with slight declines. Additionally, the sector may witness innovation-driven growth, especially in countries showing emerging potential, like Sweden.
Top countries in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics by Country
| # | 10 Countries | Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Ireland | 17,446,000,000 | 2023 | +6.62% | +8.52% | View data |
| 2 | 2 Germany | 16,473,000,000 | 2023 | +1.4% | +0.22% | View data |
| 3 | 3 France | 13,578,000,000 | 2023 | +3.42% | -0.9% | View data |
| 4 | 4 United Kingdom | 7,644,900,000 | 2023 | -0.51% | -0.55% | View data |
| 5 | 5 Italy | 7,091,400,000 | 2023 | +1.7% | +3.08% | View data |
| 6 | 6 Belgium | 6,959,400,000 | 2023 | +1.17% | +10.28% | View data |
| 7 | 7 Spain | 5,911,400,000 | 2023 | +1.36% | -0.78% | View data |
| 8 | 8 Poland | 2,101,800,000 | 2023 | +0.048% | +0.57% | View data |
| 9 | 9 Greece | 1,700,300,000 | 2023 | +3.62% | +11.63% | View data |
| 10 | 10 Hungary | 1,692,300,000 | 2023 | +1.37% | +2.26% | View data |
